top of page

Oct. 2018 | Cumulative 6-Year Survival Rate of 1,425 Luna(EVERTIS SI) Implants

  • Writer: Office Manager
    Office Manager
  • Oct 1, 2018
  • 2 min read
ree

🦷 Clinical Summary:

Title: Cumulative 6-Year Survival Rate of 1,425 Luna S Implants

Institution: Yonsei University Dental Hospital, Dept. of Periodontology

Implant System: Shinhung Luna S Implant (equivalent to Luna / Evertis SI)

Study Type: Retrospective clinical study

Period: 2010–2016

Total Implants Studied: 1,425

Total Patients: 658 (312 male, 346 female)

Mean Age: 56.4 years

Cumulative 6-Year Survival Rate: 99.86%

🧪 Key Results

  • Only 2 implant failures (due to early osseointegration failure at 1 week and 4 months)

  • No significant bone loss in representative long-term cases (≥7 years follow-up)

  • Consistent survival rate across both arches and diverse tooth positions

  • Analysis method: Kaplan-Meier and Lifetime Table Analysis (SPSS v23)

🌟 Clinical Message for Luna® (Evertis SI) Implants

This study is a powerful clinical endorsement for Luna® (Evertis SI), showing its exceptional long-term performance in a large-scale real-world setting.

✅ Key Strengths Proven by This Study:

  1. Extremely High Survival Rate→ 99.86% over 6 years across 1,425 implants

  2. Consistent Osseointegration→ Only 0.14% early failure, all within 4 months

  3. Excellent Bone Preservation→ Long-term follow-up case (7 years) shows no bone loss

  4. Reliable in All Tooth Positions→ Performance validated across molars, premolars, anterior sites

  5. Large, Trusted Clinical Base→ Data from Yonsei University Dental Hospital, one of Korea’s leading institutions

🔬 Why This Matters for Evertis SI

Although Luna S was used in the study, its design is structurally identical to Luna (Evertis SI)—excluding the prosthetic connection.This means Luna (Evertis SI) shares the same core biological, mechanical, and clinical advantages, such as:

  • Tapered body and thread design for high primary stability

  • Sand-blasted & acid-etched surface for early osseointegration

  • Bone-level design for prosthetic flexibility and esthetic cases

  • Proven success even in flapless and immediate protocols

🎯 Conclusion

With a 99.86% survival rate, this study confirms Luna’s status as one of the most clinically reliable implants on the market.

Evertis SI is not just inspired by clinical excellence —it shares the same DNA with a system already proven over thousands of cases.


 
 
 

Comments

bottom of page